Welcome to the Center for Human Reproduction (CHR), a leading fertility center located in New York City. CHR is known as a “fertility center of last resort,” primarily serving patients who have previously failed treatments elsewhere. Among CHR’s areas of special expertise are treatments of “older” ovaries, whether due to advanced female age or premature ovarian aging (POA), immunological problems affecting reproduction, repeated pregnancy loss, endometriosis, polycystic ovary syndrome (PCOS), tubal disease, male factor infertility, etc.
Why Choose Us?
Our unique approach to infertility treatment explained by Dr. Norbert Gleicher.
CHR’s widely respected physicians and scientists have greatly contributed over the years to advances in reproductive medicine and infertility. "Firsts" developed at CHR included the idea of vaginal egg retrieval, which was performed at CHR for the first time and published in the reputable medical journal The Lancet. CHR investigators also pioneered the concept of tubal catheterization to recanalize obstructed fallopian tubes, first published in the prestigious journal JAMA. The most influential recent contribution of CHR research to infertility treatment was the introduction of supplementation with DHEA in women with poor ovarian reserve. This treatment has revolutionized fertility care, and is now widely utilized all over the world.
CHR’s success is based on the close collaboration of clinicians and basic scientists who, first, try to understand the underlying pathophysiology of a problem, then try to find a therapeutic remedy. Without this kind of translational research, it would be impossible to achieve the progress CHR has experienced in its treatment outcomes over the last 10-15 years.
Our success is best represented by our patients’ voices. Success stories and patient reviews offer an opportunity to see what some patients have to say about CHR.
CHR’s physicians and scientists are well recognized by peers all over the world, not only because of the center’s large number of scientific publications but also because of the clinical outcomes CHR achieves in what, likely, represents the most adversely selected patient population of any IVF center in the US, if not the world. Multiple honors received by CHR’s physicians and scientists in the US and overseas are a reflection of CHR’s worldwide recognition as a leading fertility center. Please see the individual physicians' and scientists’ CVs for detail.
Besides offering you what we consider important basic information about infertility and fertility treatments, CHR also strives to keep the fertility community informed about current developments. For that purpose, we publish a monthly newsletter, the CHR VOICE and a bi-monthly newsletter exclusively addressing fertility preservation issues, the Fertility Preservation News. CHR also regularly publishes position papers on generally controversial issues within the profession, called OPINIONs. They are known not always to concur with opinions expressed by other colleagues. To subscribe to any of these publications, please contact us.
As a service to the medical community of Greater New York City, CHR hosts a monthly continuing medical education lecture series, the GrandRounds, usually featuring prominent scientists and/or physicians in reproductive medicine or related areas as speakers. CHR’s GrandRounds represent a rare interdisciplinary and trans-institutional opportunity for physicians and scientists to meet socially, while being exposed to state-of-the arts scientific presentations, as CHR extends complimentary admission to lecture and a subsequent dinner to residents, Obstetricians/Gynecologists and Reproductive Endocrinologists in active practice and scientists working in related areas.
Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.